Soft tissue injuries are those injuries which damage the tendons, ligaments and muscles that results into inflammation and pain. These injuries affect the mobility and day to day activities of the injured person. Most of the injuries occur due to sprain and trauma of strain on the muscles. Few treatments such as tendon transfers, muscle repairs, fasciotomies, cartilage resections or repairs, and ligament reconstructions are available in the form of surgeries for repairing the soft tissues however, they have a low success rate. However, developing better technology, superior alternatives such as modern non-invasive procedures and fast healing products are expected to boost the growth of the market.
Some of the factors which are driving the growth of soft tissue repair market are overweight population and increasing number of sports related injuries. However, lack of reimbursement and high cost of soft tissue repair products are hindering the market growth. In addition to it, the launch of new products in emerging countries is targeted to create lucrative opportunities in the market., The global soft tissue repair market is segmented into type and application. Based on the type, the market is segmented into tissue mesh, fixation devices and other. The applications segment is further segmented into dental repair, breast reconstruction, hernia repair, orthopedic repair and other.
There are various companies involved in the soft tissue repair market such as Boston Scientific Corp., Medtronic, PLC, C.R. Bard, Inc. (A Becton, Dickinson and Co.), Johnson & Johnson Service, Inc., Integra Lifesciences Corp., Organogenesis, Inc., and Arthrex, Inc. These companies are focused on developing various solutions to stay competitive in the market. Geographical expansion, merger & acquisition, finding a new market or innovate in their core competency in order to expand individual market share are the key strategies adopted by major market players. For instance, ACell, Inc. introduced Gentrix Incisional, a new implantable device comprised of the company’s proprietary MatriStem UBM technology. Gentrix Incisional is designed to reinforce soft tissue in surgical site incisions. Such product launches are expected to contribute in the growth of the market.
Research Methodology:
The market study of the global soft tissue repair market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.
Secondary Sources Include:
The report is intended for hospitals, and manufacturing companies for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
The Report Covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Boston Scientific Corp.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Medtronic, PLC
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. C.R. Bard, Inc. (A Becton, Dickinson and Co.)
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Johnson & Johnson Service, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Integra Lifesciences Corp.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Soft Tissue Repair Market by Type
5.1.1. Tissue Mesh
5.1.2. Fixation Devices
5.1.3. Other
5.2. Global Soft Tissue Repair Market by Application
5.2.1. Breast Reconstruction
5.2.2. Hernia Repair
5.2.3. Dental Repair
5.2.4. Orthopedic Repair
5.2.5. Other (Pelvic and Vaginal Prolapse Repair)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. ACell, Inc.
7.2. Allergan PLC
7.3. Arthrex, Inc.
7.4. Boston Scientific Corp.
7.5. C.R. Bard, Inc. (A Becton, Dickinson and Co.)
7.6. Cook Medical, Inc.
7.7. Herniamesh S.r.l.
7.8. Integra Lifesciences Corp.
7.9. Johnson & Johnson Service, Inc.
7.10. Koninklijke DSM N.V.
7.11. MAQUET Holding B.V. & Co. KG.
7.12. Meccellis Biotech
7.13. Medtronic, PLC
7.14. Organogenesis, Inc.
7.15. Smith & Nephew plc
7.16. Stryker Corp.
7.17. TELA Bio, Inc.
7.18. Via Surgical Ltd.
7.19. Wright Medical Group N.V.
7.20. Zimmer Biomet Holdings, Inc.